CIK 0001346830
- Non-accelerated filer
- Smaller reporting company
Tvardi Therapeutics, Inc.
Sign in to watch- Ticker
- TVRD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 713-489-8654
- Business address
- 3 SUGAR CREEK CTR. BLVD., STE 525, SUGAR LAND, TX, 77478
- Former names
- Cara Therapeutics, Inc., Cara Therapeutics Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-28 | Reilly Thomas Charles Chief Financial Officer | Grant or award | +5,333 | $10.29 | $55K | 39,855 |
| 2022-02-25 | Terrillion Scott Sec'y; Chief Compliance & G.C. | Grant or award | +20,000 | 102,412 | ||
| 2022-02-25 | Terrillion Scott Sec'y; Chief Compliance & G.C. | Sale | −1,972 | $10.29 | $20K | 100,440 |
| 2022-02-25 | Terrillion Scott Sec'y; Chief Compliance & G.C. | Grant or award · Employee Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2022-02-25 | Reilly Thomas Charles Chief Financial Officer | Grant or award | +20,000 | 34,522 | ||
| 2022-02-25 | Reilly Thomas Charles Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2022-02-25 | Posner Christopher President and CEO | Grant or award | +39,000 | 203,037 | ||
| 2022-02-25 | Posner Christopher President and CEO | Grant or award · Stock Option (Right to Buy) | +121,000 | 121,000 | ||
| 2022-02-25 | Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D | Grant or award | +20,000 | 173,679 | ||
| 2022-02-25 | Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D | Sale | −2,114 | $10.29 | $22K | 171,565 |
| 2022-02-25 | Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D | Grant or award · Employee Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2022-02-25 | Goncalves Joana Chief Medical Officer | Grant or award | +20,000 | 78,507 | ||
| 2022-02-25 | Goncalves Joana Chief Medical Officer | Sale | −1,972 | $10.29 | $20K | 76,535 |
| 2022-02-25 | Goncalves Joana Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2021-12-17 | Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D | Grant or award | +12,607 | 153,679 | ||
| 2021-12-17 | Goncalves Joana Chief Medical Officer | Grant or award | +12,607 | 58,507 | ||
| 2021-12-17 | Terrillion Scott Sec'y; Chief Compliance & G.C. | Grant or award | +11,495 | 82,412 | ||
| 2021-12-17 | Reilly Thomas Charles Chief Financial Officer | Grant or award | +11,170 | 14,522 | ||
| 2021-11-12 | Ives Jeffrey L. Director | Sale | −8,180 | $16.04 | $131K | 7,200 |
| 2021-11-01 | Goncalves Joana Chief Medical Officer | Sale | −1,000 | $17.15 | $17K | 45,900 |
Page 8 of 15 · 284 trades